Genome-wide association study identifies multiple susceptibility loci for gliomaBen Kinnersley, Richard S. Houlston, Marianne Labussière et al.|Nature Communications|2015Cited by 137
A genome-wide association study identifies susceptibility loci for primary central nervous system lymphoma at 6p25.3 and 3p22.1: a LOC Network studyKarim Labrèche, Sylvain Choquet, Maïlys Daniau et al.|Neuro-Oncology|2019Cited by 16
Ultra High-Risk Multiple Myeloma Patients with Multi-Hit Tumours and SKY92 High Risk Signature Are at Increased Risk of Early Relapse Even When Treated with Extended Intensified Induction and Consolidation - Results from the Optimum/Muknine TrialMartin Kaiser, Matthew Jenner, Graham Jackson et al.|Blood|2023Cited by 8
Extended Intensified Consolidation and Maintenance Improve Ultra High-Risk Multiple Myeloma Patient Outcome - Long-Term Follow-up of the Ukmra Optimum/Muknine TrialMartin Kaiser, Matthew Jenner, Andrew Hall et al.|Blood|2024Cited by 2